Physician profile
Lance W Perez
NPI 1427484971
$1,886.65
in general payments reported to CMS, 2019-2025
8 companies · $1,485 in 2025
The $1,485 reported for 2025 was more than what 94% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.79 · 2022: $72.96 · 2023: $217 · 2024: $95.36 · 2025: $1,485.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,244 · Food and Beverage: $553.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,244.04 |
| Food and Beverage | $552.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,509.69 | 2022-2025 | |
| Djo, LLC | $177.29 | 2023-2024 | Cmf |
| Integra Lifesciences Corporation | $56.65 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Horizon Therapeutics Plc | $47.83 | 2021-2022 | |
| Curonix LLC | $47.68 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Ethicon US, LLC | $16.95 | 2025 | Vistaseal, Stratafix |
| Orthofix Medical, INC. | $15.73 | 2023 | Physio-Stim, Spinal-Stim |
| Kowa Pharmaceuticals America, INC. | $14.83 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lance Perez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.